Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/03/24 07:05:00 on US and Canada Markets.
Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre . CEO Cr...
Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre . CEO Cr...
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing PR Newswire The partnership combines Ginkgo's AI/ML and enzyme engineering expertise with Prozomix's wealth of enzyme sequence data to create best-in-class enzymes fo...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Sportsman's Warehouse Holdings Inc. (SPWH) is expected to report $-0.3 for Q4 2024 IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2024-01-31 Klepierre (KLPEF) is expected to report for Q4 2023 Steakholder Foods Ltd. (STKH) is expected to report for Q4 2023 R...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
13.33%Change Percent:
Eyenovia Inc. Company Name:
EYEN Stock Symbol:
NASDAQ Market:
eyenovia.com Website: